MaxCyte, Inc.

MaxCyte, Inc.verified

MXCT

Price:

$4.11

Market Cap:

$433.53M

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electropora...[Read more]

Industry

Medical - Devices

IPO Date

2021-07-30

Stock Exchange

NASDAQ

Ticker

MXCT

The Enterprise Value as of December 2024 (TTM) for MaxCyte, Inc. (MXCT) is 414.89M

According to MaxCyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 414.89M. This represents a change of -0.28% compared to the average of 416.05M of the last 4 quarters.

MaxCyte, Inc. (MXCT) Historical Enterprise Value (quarterly & annually)

How has MXCT Enterprise Value performed in the past?

The mean historical Enterprise Value of MaxCyte, Inc. over the last ten years is 773.49M. The current 414.89M Enterprise Value has changed 5.26% with respect to the historical average. Over the past ten years (40 quarters), MXCT's Enterprise Value was at its highest in in the June 2021 quarter at 1.40B. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

773.49M

Median

774.12M

Minimum

457.60M

Maximum

1.17B

MaxCyte, Inc. (MXCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MaxCyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 43.26%

Maximum Annual Enterprise Value = 1.17B

Minimum Annual Increase = -36.42%

Minimum Annual Enterprise Value = 457.60M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023457.60M-18.33%
2022560.33M-36.42%
2021881.31M-24.62%
20201.17B22.97%
2019950.76M10.05%
2018863.91M7.10%
2017806.62M43.26%
2016563.05M-24.08%
2015741.63M0.14%
2014740.62M0.07%

MaxCyte, Inc. (MXCT) Average Enterprise Value

How has MXCT Enterprise Value performed in the past?

The current Enterprise Value of MaxCyte, Inc. (MXCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

633.08M

5-year avg

803.82M

10-year avg

773.49M

MaxCyte, Inc. (MXCT) Enterprise Value vs. Peers

How is MXCT’s Enterprise Value compared to its peers?

MaxCyte, Inc.’s Enterprise Value is greater than Sight Sciences, Inc. (96.90M), greater than CVRx, Inc. (263.28M), greater than NeuroPace, Inc. (390.59M), greater than Rapid Micro Biosystems, Inc. (24.69M), less than CONMED Corporation (3.06B), less than OrthoPediatrics Corp. (520.22M), less than Surmodics, Inc. (560.63M), less than Integer Holdings Corporation (5.66B), greater than Pulmonx Corporation (235.74M), less than IRadimed Corporation (635.57M), less than Orthofix Medical Inc. (769.82M), greater than ProSomnus, Inc. (40.81M), greater than Anika Therapeutics, Inc. (204.33M), less than Heska Corporation (1.26B),

Build a custom stock screener for MaxCyte, Inc. (MXCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MaxCyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MaxCyte, Inc. (MXCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MaxCyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is MaxCyte, Inc.'s Enterprise Value?

What is the highest Enterprise Value for MaxCyte, Inc. (MXCT)?

What is the 3-year average Enterprise Value for MaxCyte, Inc. (MXCT)?

What is the 5-year average Enterprise Value for MaxCyte, Inc. (MXCT)?

How does the current Enterprise Value for MaxCyte, Inc. (MXCT) compare to its historical average?